Because the possible participation of the LPA1 receptor in depression-like disorders has been proposed in a knockout model with a constitutive lifelong lack of this receptor, validation with pharmacological studies is necessary to assess the contribution of the LPA-LPA1 signalling pathway to mood disorders. This evidence concerns the gene LPA and mood disorder.